Biorationals Market Size & Share to Surpass $1.7 Billion by 2030 | Vantage Market Research
September 20, 2023 09:20 ET
|
Vantage Market Research
WASHINGTON, Sept. 20, 2023 (GLOBE NEWSWIRE) -- As per Vantage Market Research, the Global Biorationals Market has been rapidly growing over the years due to increasing usage of Biorationals therapy...
Biorationals Market to surpass USD 2.2 billion by 2032, Says Global Market Insights Inc.
May 21, 2023 23:00 ET
|
Global Market Insights Inc.
Selbyville, Delaware, May 21, 2023 (GLOBE NEWSWIRE) -- The biorationals market valuation is predicted to cross USD 2.2 billion by 2032, as reported in a research study by Global Market Insights...
Hydrocolloids Market to Reach USD 20.21 Billion by 2030, States a New Report by Next Move Strategy Consulting
February 22, 2023 09:00 ET
|
Next Move Strategy Consulting
New York, Feb. 22, 2023 (GLOBE NEWSWIRE) -- According to the report published by Next Move Strategy Consulting, the Hydrocolloids Market generated USD 13.15 billion in 2021 and is projected to reach...
Edica Group Inc. ('Edica Naturals') Announces NEW 100% Plant-Based, Vegan 'Botanical Beauty Line' on Modern Living With Kathy Ireland®
September 14, 2022 08:00 ET
|
Edica Naturals
TORONTO, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Edica Naturals is pleased to introduce its new VEGAN beauty line with its first product launch: the Advanced Eyelash Activator & Conditioning Serum....
首个抗肿瘤候选植物药“YIV-906”与索拉非尼联合治疗肝细胞癌的IIb期临床试验正式启动
April 06, 2020 07:00 ET
|
Yiviva
—— 利用整合系统生物学方法，由耶鲁大学郑永齐教授和医起共同开发的首个抗肿瘤候选植物药 中国上海，美国纽约, April 06, 2020 (GLOBE NEWSWIRE) -- 生物制药创新企业医起医药科技有限公司（Yiviva Inc.），在2020年初正式启动了YIV-906联合索拉非尼治疗乙型肝炎相关性肝细胞癌（HCC）的一线疗法IIb期研究，并于今年三月迎来了第一位受试者。 ...
Yiviva Announces Dosing of First Patient in Phase 2b Study of First-Line YIV-906 Plus Sorafenib Combination Therapy in the Treatment of Hepatocellular Carcinoma
April 06, 2020 07:00 ET
|
Yiviva
- First-in-class oncology therapeutic candidate YIV-906 applies an integrative systems biology approach -- Global study to evaluate efficacy, safety, and quality of life in patients with hepatitis...
K. Patel Phyto Extractions Adopts Senna through ABC’s Adopt-an-Herb Program
July 10, 2019 16:58 ET
|
American Botanical Council
AUSTIN, Texas, July 10, 2019 (GLOBE NEWSWIRE) -- The American Botanical Council (ABC) announces the adoption of senna (Senna alexandrina) by K. Patel Phyto Extractions Pvt. Ltd. through ABC’s...
Emerald Health Therapeutics Joint Venture Launches Cannabis-Free Endocannabinoid-Supporting Health Supplement in Canada
July 02, 2019 07:00 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, July 02, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), through its joint venture Emerald Health Naturals (“EHN”), has...
Neem Biotech Adopts Garlic and Artichoke through ABC’s Adopt-an-Herb Program
June 10, 2019 12:34 ET
|
American Botanical Council
AUSTIN, Texas, June 10, 2019 (GLOBE NEWSWIRE) -- The American Botanical Council (ABC) announces Neem Biotech’s adoptions of garlic (Allium sativum) and artichoke (Cynara cardunculus) through ABC’s...
BOTALYS Adopts Asian Ginseng through ABC’s Adopt-an-Herb Program
May 20, 2019 14:01 ET
|
American Botanical Council
AUSTIN, Texas, May 20, 2019 (GLOBE NEWSWIRE) -- AUSTIN, Texas (May 20, 2019) — The American Botanical Council (ABC) welcomes BOTALYS’ adoption of Asian ginseng (Panax ginseng) through...